You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Details for Patent: 8,758,292


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,758,292 protect, and when does it expire?

Patent 8,758,292 protects BYDUREON PEN and is included in one NDA.

Protection for BYDUREON PEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has eight patent family members in seven countries.

Summary for Patent: 8,758,292
Title:Administering apparatus with functional drive element
Abstract: An apparatus for administering a fluid product, including a housing, a product member for accomodating the fluid product and/or a reservoir for the fluid product, which product member can be moved relative to the housing from a start position to an inserted position along a longitudinal axis of the housing, a drive member in the housing and movable relative to the product member for emptying the fluid product from the product member and/or the reservoir, wherein the drive member has at least one holding element which holds the drive member in the start position of the product member and wherein, by the movement of the product member, the holding element is moved from the holding position to a released position in which the drive member is movable relative to the housing.
Inventor(s): Tschirren; Markus (Kirchberg, CH), Moser; Ulrich (Heimiswil, CH), Hirschel; Juerg (Aarau, CH), Baumert; Jan (Bern, CH), Hattler; Eric (Solothurn, CH)
Assignee: TecPharma Licensing AG (Burgdorf, CH)
Application Number:13/489,934
Patent Claim Types:
see list of patent claims
Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,758,292: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 8,758,292, exploring its claims, the patent landscape, and the implications of its issuance.

Background of the Patent

United States Patent 8,758,292, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and landscape analysis.

Patent Claims

Understanding Patent Claims

Patent claims define the scope of protection granted by a patent. They are the heart of the patent document and must be clear, concise, and supported by the patent's description[5].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Claim Construction

The interpretation of patent claims is critical. Claims must be construed to determine their scope and whether they infringe on other patents or are infringed upon. This process involves analyzing the claim language, the specification, and any relevant prosecution history[5].

Patent Landscape Analysis

What is Patent Landscape Analysis?

Patent landscape analysis is a comprehensive approach to understanding the patent environment in a specific technology area. It helps in identifying key players, trends, and potential risks or opportunities[3].

Importance in Strategic Decision-Making

This analysis is vital for business and R&D management to make informed decisions about technology development and intellectual property strategies. It can reveal high saturation in certain technology areas, indicating the need to pivot to newer inventive spaces[3].

Identifying Key Players

In the context of U.S. Patent 8,758,292, identifying the top patent owners in the relevant technology area can provide insights into the competitive landscape. This involves analyzing the patent portfolios of key players and their focus on specific niche technologies[3].

Patentability Requirements

Novelty

A patentable invention must be novel, meaning it must not have been previously known, sold, or used by others or by the inventors themselves[5].

Nonobviousness

The invention must also be nonobvious to a person with ordinary skill in the relevant area of technology. This means the invention should not be an obvious variation of existing technology[5].

Utility

The invention must be useful, meaning it must have a practical application or be capable of being used for a specific purpose[5].

Patent Prosecution Process

Filing a Provisional Patent Application

The process often begins with filing a provisional patent application, which provides a one-year period to decide whether to proceed with a non-provisional utility patent application[5].

Examination and Prosecution

During the examination phase, a patent examiner reviews the application for patentability. This process can take several years and may involve arguments and amended claims to address any issues raised by the examiner[5].

Obviousness-Type Double Patenting (ODP)

Definition and Implications

ODP is a doctrine that prevents the issuance of multiple patents for the same invention or an obvious variation of the same invention. This is particularly relevant when dealing with continuation-in-part patents or patents with overlapping claims[1].

Case Law and Statutory Language

The Federal Circuit has clarified that ODP analysis must consider the adjusted expiration date of a patent, including any Patent Term Adjustment (PTA) granted due to USPTO delays during prosecution[1].

Determining Inventorship

True and Only Inventors

U.S. patent law requires that only the true and only inventors be listed on a patent application. This involves identifying those who conceived the idea and reduced it to practice[2].

Conception and Reduction to Practice

Conception is the formation of a definite and permanent idea of the invention, while reduction to practice involves either actual reduction (building and testing the invention) or constructive reduction (filing a patent application)[2].

Commercialization and Licensing

Evaluating Commercial Potential

Before proceeding with patent prosecution, it is essential to evaluate the commercial potential of the invention. This involves assessing whether the invention is at risk of public disclosure, its commercial value, and whether it can be enabled[5].

Costs and Funding

The cost of drafting and filing a patent application can be significant, ranging from $8,000 to $20,000 for a U.S. utility patent. Commercial partners often cover these costs, especially if there is a reasonable likelihood of recovering them[5].

Key Takeaways

  • Clear Claims: Patent claims must be clear and supported by the patent's description.
  • Patent Landscape: Understanding the patent landscape is crucial for strategic decision-making.
  • Patentability: Inventions must be novel, nonobvious, and useful.
  • ODP: Obviousness-type double patenting must be considered, especially with continuation-in-part patents.
  • Inventorship: Only true and only inventors should be listed on a patent application.
  • Commercialization: Evaluating commercial potential and securing funding are critical steps.

FAQs

Q: What is the purpose of a provisional patent application?

A: A provisional patent application provides a one-year period to decide whether to proceed with a non-provisional utility patent application and allows for early filing to establish a priority date.

Q: How is obviousness determined in patent law?

A: Obviousness is determined by whether the invention would be obvious to a person with ordinary skill in the relevant area of technology, considering prior art and the differences between the invention and what is already known.

Q: What is the significance of Patent Term Adjustment (PTA)?

A: PTA adjusts the expiration date of a patent to account for delays during prosecution caused by the USPTO, ensuring that the patent term is not unfairly shortened.

Q: Why is patent landscape analysis important?

A: Patent landscape analysis helps in identifying key players, trends, and potential risks or opportunities in a specific technology area, enabling strategic decisions about technology development and intellectual property.

Q: What are the costs associated with filing and maintaining a patent?

A: The costs can range from $8,000 to $20,000 for drafting and filing a U.S. utility patent application, with additional costs incurred during prosecution and after the patent issues.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Determining Inventorship for US Patent Applications, Oregon State University.
  3. Patent Landscape Analysis - Uncovering Strategic Insights, AcclaimIP.
  4. Intellectual Property: Patent Office Should Define Quality, Reassess Processes, U.S. Government Accountability Office.
  5. Intellectual Property Protection, University of Kansas Office of Research.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,758,292

Showing 1 to 1 of 1 entries

Foreign Priority and PCT Information for Patent: 8,758,292

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2007 016 810Apr 5, 2007

International Family Members for US Patent 8,758,292

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria E516834 ⤷  Try for Free
China 101678173 ⤷  Try for Free
Denmark 2144649 ⤷  Try for Free
European Patent Office 2144649 ⤷  Try for Free
Japan 2010523181 ⤷  Try for Free
Japan 5128658 ⤷  Try for Free
Poland 2144649 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.